This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Virginia Villegas, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Virginia Villegas, M.
Right arrowPubmed/NCBI databases
*Protein
*Substance via MeSH

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2006, p. 2880-2882, Vol. 50, No. 8
0066-4804/06/$08.00+0     doi:10.1128/AAC.00186-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

First Detection of the Plasmid-Mediated Class A Carbapenemase KPC-2 in Clinical Isolates of Klebsiella pneumoniae from South America

Maria Virginia Villegas,1 Karen Lolans,2,6 Adriana Correa,1 Carlos Jose Suarez,1 Jaime A. Lopez,3 Marta Vallejo,4 John P. Quinn,2,5,6* the Colombian Nosocomial Resistance Study Group

CIDEIM (International Center for Medical Research and Training), Cali, Colombia,1 John Stroger Hospital, Chicago, Illinois,2 Hospital Pablo Tabon Uribe, Medellin, Colombia,3 Hospital General de Medellin, Medellin, Colombia,4 Rush University Medical Center, Chicago, Illinois,5 Chicago Infectious Disease Research Institute, Chicago, Illinois6

Received 10 February 2006/ Returned for modification 4 April 2006/ Accepted 26 May 2006


arrow
ABSTRACT
 
The plasmid-mediated class A carbapenemase KPC-2 was isolated from unrelated Klebsiella pneumoniae isolates in Medellin, Colombia. These KPC enzymes are the first from South America and the second isolation outside of the United States. The expanding geographic spread of KPC carbapenemases underscores the importance of clinical recognition of these enzymes.


arrow
TEXT
 
A number of resistance mechanisms can circumvent the efficacy of carbapenems. Predominant among these is the production of carbapenem-hydrolyzing ß-lactamases (carbapenemases). The small but potent group of molecular class A carbapenemases that includes KPC1-3, NmcA, Sme1-3, IMI-1, and GES-2 are sporadically characterized from enterobacterial species (14).

Within this class, the KPCs are most frequently encountered. While Klebsiella pneumoniae remains their most frequent host, its range has broadened to include Klebsiella oxytoca (3, 23), Salmonella enterica (12), and Enterobacter spp. (4, 9), and KPC-producing organisms are being increasingly detected. They are predominant in facilities in New York (3, 5, 21), where one report demonstrated an impressive 24% of K. pneumoniae producing KPCs (6). Their geographical distribution, once limited to the eastern United States, is gradually widening. A single KPC-2-producing K. pneumoniae isolate was recently reported in France (13), although a possible transfer from the United States was acknowledged in that case. We have identified two KPC-possessing K. pneumoniae isolates, collected from different facilities in Medellin, Colombia. These KPC enzymes are the second identified outside of the United States and are the first from Latin America.

During 2005, a surveillance network within Colombia identified two carbapenem-resistant K. pneumoniae isolates from different hospitals. Both patients had nosocomial infections and subsequently received meropenem. The first was diagnosed with an ultimately fatal bacteremic pneumonia. Isolate KPN2303 was recovered from blood, ascitic fluid, and urine cultures. The second patient had a urinary tract infection that resolved upon appropriate therapy, with isolate KPN633 recovered from urine cultures. No discernible linkage to the United States could be established from either patient. Isolate identification and antibiotic susceptibilities were determined by Vitek (bioMerieux, Lyon, France). Isolates were resistant to all tested antibiotics, except that KPN2303 remained susceptible to aminoglycosides while KPN633 remained susceptible to fluoroquinolones. Both were extended-spectrum beta-lactamase (ESBL) negative by Vitek. Susceptibilities by broth microdilution (7) confirmed that both isolates had unusually high-level resistance to all three carbapenems (MICs > 256 µg/ml) (Table 1), with no change or only a slight reduction in the MICs noted after the addition of clavulanic acid.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Antimicrobial susceptibility patterns of K. pneumoniae KPN2303, its E. coli XL-10 transformant, and K. pneumoniae KPN633

The first isolate identified was KPN2303. ß-Lactamases in the cell extract were examined by isoelectric focusing (IEF) (10) with concurrent evaluation in a three-dimensional extract bioassay using imipenem (8). IEF demonstrated only a single experimental pI 7.0 ß-lactamase. SHV-specific PCR on a genomic template (20) amplified blaSHV in KPN2303. However, a positive bioassay result suggested ß-lactamase involvement in imipenem hydrolysis (data not shown).

A shotgun cloning approach was used to identify the carbapenemase, and Escherichia coli XL-10 transformants were selected with ampicillin (50 µg/ml). Extracts of a transformant having a positive bioassay result revealed transfer of the pI 7.0 ß-lactamase on IEF. The entire 4.67-kb insert of the plasmid (pBC-Wilma) was sequenced. Sequence homologies were determined using the BLAST program from the National Center for Biotechnology Information (1), revealing the presence of a KPC-type ß-lactamase, blaKPC-2 (Fig. 1). Nucleotides 1 through 2808 had a 99% identity to a cloned blaKPC-2 containing a HindIII fragment as described by Miriagou et al. (12) (GenBank accession no. AF481906) from the Salmonella enterica subsp. enterica serovar Cubana plasmid, pST4707. The open reading frames (ORFs) flanking blaKPC-2 on the BamHI fragment (orf1 and orf2) (Fig. 1) encode proteins associated with mobile genetic elements. orf1 had 100% identity to the terminal partial gene for a putative transposition helper protein (GenBank accession no. AAM10642.1). orf2 had 100% identity with the proximal partial gene for a putative transposase (GenBank accession no. AAM10644.1). No additional ORFs were identified downstream. Interestingly, there did exist downstream a 155-bp region identical at the nucleotide level to Tn5708 (GenBank accession no. AJ010745) that may represent the now-defunct vestiges of a transposon.


Figure 1
View larger version (5K):
[in this window]
[in a new window]
  		FIG. 1. Schematic representation (not to scale) of the cloned plasmid 4.67-kb BamHI insert from KPN2303. Open reading frames and transcriptional orientation are represented by arrows. GenBank sequences listed below ORFs represent those with the most significant similarity. The dashed line represents the upstream portion of AF481906 not included in our cloned fragment.

The transformant showed only moderately reduced carbapenem susceptibilities compared to those of the clinical strain (Table 1), suggesting that additional resistance mechanisms may contribute to that high-level resistance. Although not examined, alterations in porin expression are known to affect the MICs of these antibiotics in Klebsiella (2, 22).

This evaluation of KPN2303 was completed before identification of KPN633. Thus, PCR analysis with KPC primers and conditions (22) as well as sequencing of the pCR-XL-TOPO (Invitrogen, Carlsbad, CA) cloned amplicon confirmed blaKPC-2 in KPN633. Chromosomal DNA was fingerprinted by pulsed-field gel electrophoresis with XbaI digestion (Invitrogen, Carlsbad, CA) (11) and indicated that these isolates were unrelated (data not shown).

Our experimental pI of 7.0 differed from the published KPC-2 pI of 6.7. This discrepancy led to the cloning approach utilized and recognition of similarities to the Salmonella plasmid that might not have been otherwise ascertained. Other notable similarities to pST4707 identified include a New York K. oxytoca isolate (23) and the recent KPC-2-producing French K. pneumoniae isolate (13). While the precise relationship of our isolates to these strains has not been investigated, the resemblance of genetic structures from multiple strains and hosts suggests dissemination of the KPC-2 ß-lactamase through conjugal plasmid transfer and transposition.

Southern transfer of plasmids to a positively charged nylon membrane (Roche, Indianapolis, IN) (15) was performed. A blaKPC-2 probe hybridized under high-stringency conditions to single plasmids of 15.5 and ~30 Kb in KPN633 and KPN2303, respectively (data not shown). Attempts to transfer ß-lactam resistance from both K. pneumoniae strains to Escherichia coli J53 AzR by a mixed broth mating procedure (17) were unsuccessful.

In areas with a high prevalence of ESBL producers, as in Colombia (32.6%) (19), carbapenems remain one of the few therapies for Klebsiella infections (16). As KPC-producing organisms are frequently resistant to multiple antibiotic classes (3, 6, 23), the detection of this plasmid-mediated resistance mechanism is worrisome. Current evidence suggests that the significance and prevalence of these carbapenemases may be clinically unrecognized. Multiple factors can complicate the detection process. First, carriage of the blaKPC allele may confer only reduced carbapenem susceptibility but not frank resistance (18). Second, KPCs have been associated with positive ESBL confirmation tests (18), leading to their misidentification as ESBL-producing strains. Third, an inoculum effect exists (6) for some isolates in the low-inoculum type tests employed by some automated systems. Accurate detection of KPC enzymes will be crucial in controlling their spread, especially in isolates remaining susceptible in vitro.

Nucleotide sequence accession number. The nucleotide sequence of the BamHI fragment obtained from K. pneumoniae KPN2303 was assigned GenBank accession no. DQ523564.


arrow
ACKNOWLEDGMENTS
 
The conformation of the network of institutions from the Colombian Nosocomial Resistance Study Group and funding for this study were made possible thanks in part to the support of Bristol Myers Squibb, Colombia, Pfizer Inc., Groton, CT; Merck Research Laboratories, Whitehouse Station, NJ; and the Chicago Infectious Disease Research Institute, Chicago, IL.

We also thank the participating institutions from the Colombian Nosocomial Resistance Study Group, whose members are the following: CIDEIM group, Sandra Reyes and Maria Consuelo Miranda; Cali group, Ernesto Martínez, Lena Barrera, Luz Marina Gallardo, and Alba Lucía Bohorquez; Bogotá group, Carlos Alquichire, Martha Ruiz, Nancy Obando, Pilar Hurtado, Gladys Ceballos, Andrés Torres, Henry Mendoza, Alba Lucía Sanín, Martha Patricia Meléndez, Sara Maria Quintero, Eugenia Janeth López, Cristina Matiz, Sonia Cuervo, Jorge Cortés, Maria Cristina Paredes, Patricia Arroyo, Diana Bermudez, and Aura Lucía Leal; Medellín group, Carlos Ignacio Gomez, Jaime Lopez, Monica Cuartas, Celina Gomez, Ana Lucia Correa, Julián Betancourth, Esteban Echavarria, Juan David Villa, Ana Cristina Quiroga, Luz Amparo Alvarez, Claudia Patricia Alvarez, Eugenia Loaiza, Claudia Hoyos, and Rubén Darío Trejos; Barranquilla group, Rubén Darío Camargo, Adriana Marín, and Angela Mendoza; Pereira group, Carmen Elisa Llano, Myriam Gómez, and Araceli Cano; Bucaramanga group, Claudia Bárcenas, Adriana Pinto, and Luis Angel Villar.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: John Stroger Hospital, 1900 W. Polk, Rm 1258, Chicago, IL 60612. Phone: (312) 864-4874. Fax: (312) 864-9522. E-mail: ESBLman{at}yahoo.com. Back


arrow
REFERENCES
 
    1
  1. Altschul, S. F., T. L. Madden, A. A. Schäffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.[Abstract/Free Full Text]
    2. 2
  2. Ardanuy, C., J. Linares, M. A. Dominguez, S. Hernandez-Alles, V. J. Benedi, and L. Martinez-Martinez. 1998. Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. Antimicrob. Agents Chemother. 42:1636-1640.[Abstract/Free Full Text]
    3. 3
  3. Bradford, P. A., S. Bratu, C. Urban, M. Visalli, N. Mariano, D. Landman, J. J. Rahal, S. Brooks, S. Cebular, and J. Quale. 2004. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin. Infect. Dis. 39:55-60.[CrossRef][Medline]
    4. 4
  4. Bratu, S., D. Landman, M. Alam, E. Tolentino, and J. Quale. 2005. Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York. Antimicrob. Agents Chemother. 49:776-778.[Abstract/Free Full Text]
    5. 5
  5. Bratu, S., D. Landman, R. Haag, R. Recco, A. Eramo, M. Alam, and J. Quale. 2005. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch. Intern. Med. 165:1430-1435.[Abstract/Free Full Text]
    6. 6
  6. Bratu, S., M. Mooty, S. Nichani, D. Landman, C. Gullans, B. Pettinato, U. Karumudi, P. Tolaney, and J. Quale. 2005. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob. Agents Chemother. 49:3018-3020.[Abstract/Free Full Text]
    7. 7
  7. Clinical and Laboratory Standards Institute. 2005. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. CLSI document M7-A6. Clinical and Laboratory Standards Institute, 6th ed., Wayne, Pa.
    8. 8
  8. Coudron, P. E., E. S. Moland, and K. S. Thomson. 2000. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veteran's medical center. J. Clin. Microbiol. 38:1791-1796.[Abstract/Free Full Text]
    9. 9
  9. Hossain, A., M. J. Ferraro, R. M. Pino, R. B. Dew III, E. S. Moland, T. J. Lockhart, K. S. Thomson, R. V. Goering, and N. D. Hanson. 2004. Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp. Antimicrob. Agents Chemother. 48:4438-4440.[Abstract/Free Full Text]
    10. 10
  10. Matthew, A., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of beta-lactamases. J. Gen. Microbiol. 88:169-178.[Medline]
    11. 11
  11. Matushek, M. G., M. J. Bonten, and M. K. Hayden. 1996. Rapid preparation of bacterial DNA for pulsed-field gel electrophoresis. J. Clin. Microbiol. 34:2598-2600.[Abstract]
    12. 12
  12. Miriagou, V., L. S. Tzouvelekis, S. Rossiter, E. Tzelepi, F. J. Angulo, and J. M. Whichard. 2003. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob. Agents Chemother. 47:1297-1300.[Abstract/Free Full Text]
    13. 13
  13. Naas, T., P. Nordmann, G. Vedel, and C. Poyart. 2005. Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob. Agents Chemother. 49:4423-4424.[Free Full Text]
    14. 14
  14. Nordmann, P., and L. Poirel. 2002. Emerging carbapenemases in gram-negative aerobes. Clin. Microbiol. Infect. 8:321-331.[CrossRef][Medline]
    15. 15
  15. Odeh, R., S. Kelkar, A. M. Hujer, R. A. Bonomo, P. C. Schreckenberger, and J. P. Quinn. 2002. Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli. Clin. Infect. Dis. 35:140-145.[CrossRef][Medline]
    16. 16
  16. Paterson, D. L. 2000. Recommendations for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs). Clin. Microbiol. Infect. 6:460-463.[CrossRef][Medline]
    17. 17
  17. Rasheed, J. K., G. J. Anderson, H. Yigit, A. M. Queenan, A. Domenech-Sanchez, J. M. Swenson, J. W. Biddle, M. J. Ferraro, G. A. Jacoby, and F. C. Tenover. 2000. Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18. Antimicrob. Agents Chemother. 44:2382-2388.[Abstract/Free Full Text]
    18. 18
  18. Smith Moland, E., N. D. Hanson, V. L. Herrera, J. A. Black, T. J. Lockhart, A. Hossain, J. A. Johnson, R. V. Goering, and K. S. Thomson. 2003. Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J. Antimicrob. Chemother. 51:711-714.[Abstract/Free Full Text]
    19. 19
  19. Villegas, M. V., A. Correa, F. Perez, M. C. Miranda, T. Zuluaga, J. P. Quinn, and the Colombian Nosocomial Resistance Study Group. 2004. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Diagn. Microbiol. Infect. Dis. 49:217-222.[CrossRef][Medline]
    20. 20
  20. Wang, H., S. Kelkar, W. Wu, M. Chen, and J. P. Quinn. 2003. Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China. Antimicrob. Agents Chemother. 47:790-793.[Abstract/Free Full Text]
    21. 21
  21. Woodford, N., P. M. Tierno, Jr., K. Young, L. Tysall, M. F. Palepou, E. Ward, R. E. Painter, D. F. Suber, D. Shungu, L. L. Silver, K. Inglima, J. Kornblum, and D. M. Livermore. 2004. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York medical center. Antimicrob. Agents Chemother. 48:4793-4799.[Abstract/Free Full Text]
    22. 22
  22. Yigit, H., A. M. Queenan, G. J. Anderson, A. Domenech-Sanchez, J. W. Biddle, C. D. Steward, S. Alberti, K. Bush, and F. C. Tenover. 2001. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161.[Abstract/Free Full Text]
    23. 23
  23. Yigit, H., A. M. Queenan, J. K. Rasheed, J. W. Biddle, A. Domenech-Sanchez, S. Alberti, K. Bush, and F. C. Tenover. 2003. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2. Antimicrob. Agents Chemother. 47:3881-3889.[Abstract/Free Full Text]

Antimicrobial Agents and Chemotherapy, August 2006, p. 2880-2882, Vol. 50, No. 8
0066-4804/06/$08.00+0     doi:10.1128/AAC.00186-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Shen, P., Wei, Z., Jiang, Y., Du, X., Ji, S., Yu, Y., Li, L. (2009). Novel Genetic Environment of the Carbapenem-Hydrolyzing {beta}-Lactamase KPC-2 among Enterobacteriaceae in China. Antimicrob. Agents Chemother. 53: 4333-4338 [Abstract] [Full Text]  
  • Stachyra, T., Levasseur, P., Pechereau, M.-C., Girard, A.-M., Claudon, M., Miossec, C., Black, M. T. (2009). In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases. J Antimicrob Chemother 64: 326-329 [Abstract] [Full Text]  
  • Akpaka, P. E., Swanston, W. H., Ihemere, H. N., Correa, A., Torres, J. A., Tafur, J. D., Montealegre, M. C., Quinn, J. P., Villegas, M. V. (2009). Emergence of KPC-Producing Pseudomonas aeruginosa in Trinidad and Tobago. J. Clin. Microbiol. 47: 2670-2671 [Abstract] [Full Text]  
  • Kitchel, B., Rasheed, J. K., Patel, J. B., Srinivasan, A., Navon-Venezia, S., Carmeli, Y., Brolund, A., Giske, C. G. (2009). Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258. Antimicrob. Agents Chemother. 53: 3365-3370 [Abstract] [Full Text]  
  • Toye, B., Krajden, S., Fuksa, M., Low, D. E., Pillai, D. R. (2009). Carbapenem resistance in Canada. CMAJ 180: 1225-1226 [Full Text]  
  • Pavez, M., Mamizuka, E. M., Lincopan, N. (2009). Early Dissemination of KPC-2-Producing Klebsiella pneumoniae Strains in Brazil. Antimicrob. Agents Chemother. 53: 2702-2702 [Full Text]  
  • Gootz, T. D., Lescoe, M. K., Dib-Hajj, F., Dougherty, B. A., He, W., Della-Latta, P., Huard, R. C. (2009). Genetic Organization of Transposase Regions Surrounding blaKPC Carbapenemase Genes on Plasmids from Klebsiella Strains Isolated in a New York City Hospital. Antimicrob. Agents Chemother. 53: 1998-2004 [Abstract] [Full Text]  
  • Endimiani, A., Hujer, A. M., Perez, F., Bethel, C. R., Hujer, K. M., Kroeger, J., Oethinger, M., Paterson, D. L., Adams, M. D., Jacobs, M. R., Diekema, D. J., Hall, G. S., Jenkins, S. G., Rice, L. B., Tenover, F. C., Bonomo, R. A. (2009). Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J Antimicrob Chemother 63: 427-437 [Abstract] [Full Text]  
  • Wolter, D. J., Kurpiel, P. M., Woodford, N., Palepou, M.-F. I., Goering, R. V., Hanson, N. D. (2009). Phenotypic and Enzymatic Comparative Analysis of the Novel KPC Variant KPC-5 and Its Evolutionary Variants, KPC-2 and KPC-4. Antimicrob. Agents Chemother. 53: 557-562 [Abstract] [Full Text]  
  • Navon-Venezia, S., Leavitt, A., Schwaber, M. J., Rasheed, J. K., Srinivasan, A., Patel, J. B., Carmeli, Y., and the Israeli KPC Kpn Study Group, (2009). First Report on a Hyperepidemic Clone of KPC-3-Producing Klebsiella pneumoniae in Israel Genetically Related to a Strain Causing Outbreaks in the United States. Antimicrob. Agents Chemother. 53: 818-820 [Abstract] [Full Text]  
  • Cole, J. M., Schuetz, A. N., Hill, C. E., Nolte, F. S. (2009). Development and Evaluation of a Real-Time PCR Assay for Detection of Klebsiella pneumoniae Carbapenemase Genes. J. Clin. Microbiol. 47: 322-326 [Abstract] [Full Text]  
  • Monteiro, J., Santos, A. F., Asensi, M. D., Peirano, G., Gales, A. C. (2009). First Report of KPC-2-Producing Klebsiella pneumoniae Strains in Brazil. Antimicrob. Agents Chemother. 53: 333-334 [Full Text]  
  • Marschall, J., Tibbetts, R. J., Dunne, W. M. Jr., Frye, J. G., Fraser, V. J., Warren, D. K. (2009). Presence of the KPC Carbapenemase Gene in Enterobacteriaceae Causing Bacteremia and Its Correlation with In Vitro Carbapenem Susceptibility. J. Clin. Microbiol. 47: 239-241 [Abstract] [Full Text]  
  • Woodford, N., Zhang, J., Warner, M., Kaufmann, M. E., Matos, J., MacDonald, A., Brudney, D., Sompolinsky, D., Navon-Venezia, S., Livermore, D. M. (2008). Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother 62: 1261-1264 [Abstract] [Full Text]  
  • Pavez, M., Neves, P., Dropa, M., Matte, M. H., Grinbaum, R. S., Elmor de Araujo, M. R., Mamizuka, E. M., Lincopan, N. (2008). Emergence of carbapenem-resistant Escherichia coli producing CMY-2-type AmpC {beta}-lactamase in Brazil. J Med Microbiol 57: 1590-1592 [Full Text]  
  • Petrella, S., Ziental-Gelus, N., Mayer, C., Renard, M., Jarlier, V., Sougakoff, W. (2008). Genetic and Structural Insights into the Dissemination Potential of the Extremely Broad-Spectrum Class A {beta}-Lactamase KPC-2 Identified in an Escherichia coli Strain and an Enterobacter cloacae Strain Isolated from the Same Patient in France. Antimicrob. Agents Chemother. 52: 3725-3736 [Abstract] [Full Text]  
  • Hindiyeh, M., Smollen, G., Grossman, Z., Ram, D., Davidson, Y., Mileguir, F., Vax, M., Ben David, D., Tal, I., Rahav, G., Shamiss, A., Mendelson, E., Keller, N. (2008). Rapid Detection of blaKPC Carbapenemase Genes by Real-Time PCR. J. Clin. Microbiol. 46: 2879-2883 [Abstract] [Full Text]  
  • Cai, J. C., Zhou, H. W., Zhang, R., Chen, G.-X. (2008). Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates Possessing the Plasmid-Mediated Carbapenem-Hydrolyzing {beta}-Lactamase KPC-2 in Intensive Care Units of a Chinese Hospital. Antimicrob. Agents Chemother. 52: 2014-2018 [Abstract] [Full Text]  
  • Rasheed, J. K., Biddle, J. W., Anderson, K. F., Washer, L., Chenoweth, C., Perrin, J., Newton, D. W., Patel, J. B. (2008). Detection of the Klebsiella pneumoniae Carbapenemase Type 2 Carbapenem-Hydrolyzing Enzyme in Clinical Isolates of Citrobacter freundii and K. oxytoca Carrying a Common Plasmid. J. Clin. Microbiol. 46: 2066-2069 [Abstract] [Full Text]  
  • Naas, T., Cuzon, G., Villegas, M.-V., Lartigue, M.-F., Quinn, J. P., Nordmann, P. (2008). Genetic Structures at the Origin of Acquisition of the {beta}-Lactamase blaKPC Gene. Antimicrob. Agents Chemother. 52: 1257-1263 [Abstract] [Full Text]  
  • Giske, C. G., Monnet, D. L., Cars, O., Carmeli, Y., on behalf of ReAct-Action on Antibiotic Resistance, (2008). Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli. Antimicrob. Agents Chemother. 52: 813-821 [Full Text]  
  • Zhang, R., Yang, L., Cai, J. C., Zhou, H. W., Chen, G.-X. (2008). High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression. J Med Microbiol 57: 332-337 [Abstract] [Full Text]  
  • Mendes, R. E., Bell, J. M., Turnidge, J. D., Yang, Q., Yu, Y., Sun, Z., Jones, R. N. (2008). Carbapenem-Resistant Isolates of Klebsiella pneumoniae in China and Detection of a Conjugative Plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 Gene. Antimicrob. Agents Chemother. 52: 798-799 [Full Text]  
  • Walther-Rasmussen, J., Hoiby, N. (2007). Class A carbapenemases. J Antimicrob Chemother 60: 470-482 [Abstract] [Full Text]  
  • Leavitt, A., Navon-Venezia, S., Chmelnitsky, I., Schwaber, M. J., Carmeli, Y. (2007). Emergence of KPC-2 and KPC-3 in Carbapenem-Resistant Klebsiella pneumoniae Strains in an Israeli Hospital. Antimicrob. Agents Chemother. 51: 3026-3029 [Abstract] [Full Text]  
  • Anderson, K. F., Lonsway, D. R., Rasheed, J. K., Biddle, J., Jensen, B., McDougal, L. K., Carey, R. B., Thompson, A., Stocker, S., Limbago, B., Patel, J. B. (2007). Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae. J. Clin. Microbiol. 45: 2723-2725 [Abstract] [Full Text]  
  • Villegas, M. V., Lolans, K., Correa, A., Kattan, J. N., Lopez, J. A., Quinn, J. P., and the Colombian Nosocomial Resistance Study Grou, (2007). First Identification of Pseudomonas aeruginosa Isolates Producing a KPC-Type Carbapenem-Hydrolyzing {beta}-Lactamase. Antimicrob. Agents Chemother. 51: 1553-1555 [Abstract] [Full Text]  
  • Wei, Z.-Q., Du, X.-X., Yu, Y.-S., Shen, P., Chen, Y.-G., Li, L.-J. (2007). Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae Isolate from China. Antimicrob. Agents Chemother. 51: 763-765 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Virginia Villegas, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Virginia Villegas, M.
Right arrowPubmed/NCBI databases
*Protein
*Substance via MeSH

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»